These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10671399)

  • 1. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.
    Laakso A; Vilkman H; Alakare B; Haaparanta M; Bergman J; Solin O; Peurasaari J; Räkköläinen V; Syvälahti E; Hietala J
    Am J Psychiatry; 2000 Feb; 157(2):269-71. PubMed ID: 10671399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of detached personality in healthy subjects by low dopamine transporter binding.
    Laakso A; Vilkman H; Kajander J; Bergman J; paranta M; Solin O; Hietala J
    Am J Psychiatry; 2000 Feb; 157(2):290-2. PubMed ID: 10671406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia.
    Laakso A; Bergman J; Haaparanta M; Vilkman H; Solin O; Syvälahti E; Hietala J
    Schizophr Res; 2001 Oct; 52(1-2):115-20. PubMed ID: 11595398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
    Nurmi E; Bergman J; Eskola O; Solin O; Hinkka SM; Sonninen P; Rinne JO
    J Cereb Blood Flow Metab; 2000 Nov; 20(11):1604-9. PubMed ID: 11083235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.
    Hsiao MC; Lin KJ; Liu CY; Tzen KY; Yen TC
    Schizophr Res; 2003 Dec; 65(1):39-46. PubMed ID: 14623373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
    Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
    Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
    Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Sakamoto M
    Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
    Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
    Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.
    Ouchi Y; Yoshikawa E; Okada H; Futatsubashi M; Sekine Y; Iyo M; Sakamoto M
    Ann Neurol; 1999 May; 45(5):601-10. PubMed ID: 10319882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?
    Xu C; Reith ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1340-8. PubMed ID: 8819521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
    Nurmi E; Ruottinen HM; Kaasinen V; Bergman J; Haaparanta M; Solin O; Rinne JO
    Ann Neurol; 2000 Jun; 47(6):804-8. PubMed ID: 10852547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
    Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
    Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
    Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
    Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
    World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia.
    Yoder KK; Hutchins GD; Morris ED; Brashear A; Wang C; Shekhar A
    Schizophr Res; 2004 Dec; 71(2-3):371-5. PubMed ID: 15474908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain.
    Madras BK; Gracz LM; Meltzer PC; Liang AY; Elmaleh DR; Kaufman MJ; Fischman AJ
    Synapse; 1998 Jun; 29(2):105-15. PubMed ID: 9593101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.
    van Dyck CH; Quinlan DM; Cretella LM; Staley JK; Malison RT; Baldwin RM; Seibyl JP; Innis RB
    Am J Psychiatry; 2002 Feb; 159(2):309-12. PubMed ID: 11823278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.